RAPT Therapeutics, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023
Profitability
EBT Margin -1,029.39%-1,814.95%-5,618.53%
EBIT Margin -1,055.41%-1,815.08%-5,618.53%
EBITDA Margin -1,052.94%-1,815.71%-5,478.59%
Operating Margin -1,055.41%-1,815.08%-5,618.53%
Net Margin -1,049.03%-1,814.95%-5,618.53%
FCF Margin -810.97%-1,620.27%-4,689.98%
Efficiency
Assets Average 158.80M232.42M219.77M
Equity Average 145.28M215.77M196.10M
Invested Capital 104.18M186.38M245.17M147.03M
Asset Utilization Ratio 0.020.01
Leverage & Solvency
Equity Ratio 0.880.940.920.85
Valuation
Enterprise Value 602.76M373.46M895.57M343.17M695.88M
Market Capitalization 602.76M484.97M1,085.23M592.23M854.75M
Return Ratios
Return on Sales -10.49%-18.15%-56.19%
Return on Capital Employed -0.46%-0.39%-0.64%
Return on Assets -0.44%-0.37%-0.58%
Return on Equity -0.48%-0.40%-0.65%